BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33858195)

  • 1. Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins.
    Chatzisideri T; Dalezis P; Leonidis G; Bousis S; Trafalis D; Bianchini F; Sarli V
    Future Med Chem; 2021 May; 13(10):877-895. PubMed ID: 33858195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.
    Chatzisideri T; Thysiadis S; Katsamakas S; Dalezis P; Sigala I; Lazarides T; Nikolakaki E; Trafalis D; Gederaas OA; Lindgren M; Sarli V
    Eur J Med Chem; 2017 Dec; 141():221-231. PubMed ID: 29031069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel c(RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy.
    Thysiadis S; Katsamakas S; Dalezis P; Chatzisideri T; Trafalis D; Sarli V
    Future Med Chem; 2017 Dec; 9(18):2181-2196. PubMed ID: 29110537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
    Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
    Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of peptide-NSAID conjugates for targeted cancer therapy.
    Shokri B; Zarghi A; Shahhoseini S; Mohammadi R; Kobarfard F
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1800379. PubMed ID: 31318093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
    Chen X; Plasencia C; Hou Y; Neamati N
    J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate.
    López Rivas P; Müller C; Breunig C; Hechler T; Pahl A; Arosio D; Belvisi L; Pignataro L; Dal Corso A; Gennari C
    Org Biomol Chem; 2019 May; 17(19):4705-4710. PubMed ID: 31020985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel dual-cyclic RGD peptides for α
    Liu J; Cheng X; Tian X; Guan D; Ao J; Wu Z; Huang W; Le Z
    Bioorg Med Chem Lett; 2019 Apr; 29(7):896-900. PubMed ID: 30732943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugates of a novel 7-substituted camptothecin with RGD-peptides as α(v)β₃ integrin ligands: An approach to tumor-targeted therapy.
    Dal Pozzo A; Esposito E; Ni M; Muzi L; Pisano C; Bucci F; Vesci L; Castorina M; Penco S
    Bioconjug Chem; 2010 Nov; 21(11):1956-67. PubMed ID: 20949910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.
    Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T
    ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of cucurbitacin as an anticancer drug.
    Li Y; Li Y; Yao Y; Li H; Gao C; Sun C; Zhuang J
    Biomed Pharmacother; 2023 Dec; 168():115707. PubMed ID: 37862969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
    Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
    Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cucurbitacins inspired organic synthesis: Potential dual inhibitors targeting EGFR - MAPK pathway.
    Mahnashi M; Elgazwi SM; Ahmed MS; Halaweish FT
    Eur J Med Chem; 2019 Jul; 173():294-304. PubMed ID: 31022583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
    Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
    J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expeditious Total Synthesis of Hemiasterlin through a Convergent Multicomponent Strategy and Its Use in Targeted Cancer Therapeutics.
    Charoenpattarapreeda J; Walsh SJ; Carroll JS; Spring DR
    Angew Chem Int Ed Engl; 2020 Dec; 59(51):23045-23050. PubMed ID: 32894646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
    Cai Y; Fang X; He C; Li P; Xiao F; Wang Y; Chen M
    Am J Chin Med; 2015; 43(7):1331-50. PubMed ID: 26503558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α
    Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U
    ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [
    Mohammadi R; Shokri B; Shamshirian D; Zarghi A; Shahhosseini S
    Daru; 2020 Jun; 28(1):87-96. PubMed ID: 31845157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.